| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

( Department of Cancer Research, Medical Research Institute, Michael Reese Hospital,,
Chicago 16, Ill.)
x C3H
)F1, DBA, and C3H mice. This chronic treatment was continued for periods ranging up to 18 months and total amounts of urethan as high as 1800 mg/mouse. * This work was supported by research grants from the Damon Runyon Memorial Fund (DRG-250) and the U.S. Public Health Service (C-3787).
Supported, in part, by the Foundation for Cancer Research, Chicago, and its affiliates: Bertha Adlerblum Memorial Cancer League and Mildred Lasser Balter Cancer Memorial.
Received 6/30/58.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |